Navigation Links
Foundation for the NIH Announces Lurie Prize Recognizing Outstanding Achievement by a Young Biomedical Scientist
Date:2/26/2013

Bethesda, MD (PRWEB) February 26, 2013

The Foundation for the National Institutes of Health (FNIH) announced today that Ruslan M. Medzhitov, PhD, David W. Wallace Professor of Immunobiology and Howard Hughes Medical Institute Investigator at Yale University School of Medicine, has been awarded the inaugural Lurie Prize in the Biomedical Sciences for seminal discoveries related to the innate immune system, the human body's first line of defense against invading organisms which cause infection.

A jury of eminent scientists headed by Solomon Snyder, MD, Director-Emeritus of The Solomon H. Snyder Department of Neuroscience at Johns Hopkins University, selected Medzhitov, 46, for the honor from a group of 154 nominees. The annual prize honors early-career researchers whose findings have advanced basic biomedical science. The award, which carries an honorarium of $100,000, will be presented to Medzhitov at a ceremony on Tuesday, May 14 in Chicago.

The innate immune system rapidly mobilizes a response to infection and, together with the adaptive immune system, is crucial to protecting human health. In laying out the rationale for granting the award, Snyder said Medzhitov discovered and characterized a class of proteins called Toll-like receptors which recognize and facilitate the immune response to toxic proteins.

“Dr. Medzhitov's painstaking studies paved the way for the identification of multiple TLR family members and their respective ligands which help bind molecules forming larger complexes, advancing the entire field of immunology and opening the way for the development of new vaccines and treatments” Snyder said. “He is a true pioneer of medical science.”

Born in Tashkent in the former Soviet Republic of Uzbekistan, Dr. Medzhitov studied biology and biochemistry when financial resources for scientific research were scarce. While poring over single copies of medical journals, he discovered an article by Dr. Charles A. Janeway, Jr. that sparked his interest in immunology and eventually led to a fellowship in the U.S. and current professorship in immunobiology at Yale University, in New Haven, Connecticut.

“I am very grateful to be the first recipient of the Lurie Prize and appreciate the recognition of not only my own work but that of young scientists in biomedical research who will be so recognized in the future,” said Medzhitov.

The Lurie Prize was established by well-known, global philanthropist Ann Lurie. It reflects her passion for advancing biomedical research and medical care. Her significant financial commitments have launched and benefited research and development, as well as patient care initiatives at the University of Michigan; Northwestern University; the recently-dedicated Ann and Robert H. Lurie Children's Hospital of Chicago; and health initiatives in Kenya, China and Rwanda.

“My specific interest is to reward and acknowledge a scientist who makes a discovery that is clearly a game changer in terms of medical and biological research,” said Ms. Lurie.

The Lurie Prize recognizes young scientists, defined as individuals under the age of 52, who have made paradigm changing contributions to biomedical research.

“The Lurie Prize celebrates biomedical research and more importantly, the most outstanding young investigator on the basis of his or her body of work,” said Maria Freire, PhD, President of the FNIH.  “Dr. Medzhitov is one of the most brilliant scientists in the field of immunology today and we are proud to present to him this inaugural prize.”

“The FNIH is grateful to Ann Lurie for her tireless work in promoting investment in medical research,” said Charles A. Sanders, MD, Chairman of the FNIH.  “We are particularly thankful for her unwavering support of young scientists like Dr. Medzhitov whose work is leading the way in the field of immunology.”

For more information on Dr. Medzhitov's discovery and the Lurie Prize, please visit: http://www.fnih.org.

###

About the Foundation for the NIH
Established by the United States Congress to support the mission of the NIH—improving health through scientific discovery in the search for cures—the Foundation for the NIH is a leader in identifying and addressing complex scientific and health issues. The foundation is a non-profit, 501(c)(3) charitable organization that raises private-sector funds for a broad portfolio of unique programs that complement and enhance NIH priorities and activities. For additional information about the Foundation for the NIH, please visit http://www.fnih.org.

Read the full story at http://www.prweb.com/releases/Lurie/Prize/prweb10413667.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. The Drugs for Neglected Diseases initiative (DNDi) takes the BBVA Foundation Frontiers of Knowledge Award in the Development Cooperation category
2. Brain Research Foundation 2013 Scientific Innovations Awards To Dr. Jean Hebert and Dr. Brian Litt
3. GUARDaHEART Foundation Hosts Love Your Heart Day Event in Celebration of Heart Disease Awareness Month
4. The Elsevier Foundation, TWAS, and OWSD Honor Early Career Women Scientists in Developing Countries at the Annual AAAS Meeting
5. USANA True Health Foundation Sponsors 777 Project - One Man To Run 7 Marathons In 7 Days On 7 Continents
6. TNI BioTech Acquires Exclusive License To The Portfilio Of Patents Of Dr Ian S. Zagon, Dr. Patricia J. McLauglin And Dr. Jill Smith From The Penn State Research Foundation
7. OsteoVantage™ Receives Grant from the National Science Foundation
8. The BBVA Foundation Frontiers of Knowledge Award goes to Coleman and Friedman, discoverers of the appetite hormone
9. ASAE Foundation Announces Winners of the Innovation Grant Program
10. DuPont, American Farm Bureau Foundation Invests $250,000 in My American Farm Web Education Program
11. Epilepsy Foundation and Epilepsy Therapy Project Finalize Merger To Create Strong, Unified Organization To Support People with Epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... , Feb. 20, 2017  At the 2017 ... Orlando , IBM (NYSE: ... and clients. IBM Chairman, President and CEO ... keynote address today from 8:30-10 am ET, broadcast ... and ibm.com/industries/healthcare. Her remarks examine the advent of ...
(Date:2/18/2017)... IL (PRWEB) , ... February 17, 2017 , ... ... Blood and Marrow Transplantation (ASBMT) and the Center for International Blood & Marrow ... Convention Center in Orlando, Fla. , The combined scientific sessions offer ...
(Date:2/17/2017)... 17, 2017  BioGenex, a global leader in ... a novel system for quantitative immunohistochemistry (IHC). The ... of Rochester (NY, USA) and Konica-Minolta Inc. ( ... is able to accurately quantify the expression of ... growth factor receptor-2) in clinical samples. Quantitative IHC ...
(Date:2/16/2017)... ... 16, 2017 , ... EIT Digital has launched work to develop ... Pilot studies are about to get under way for the framework, which is designed ... The concept is expected to be transferred eventually to other industries that also require ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 8, 2017 About Voice ... voice to match it against a stored voiceprint ... as pitch, cadence, and tone are compared to ... minimal hardware installation, as most PCs already have ... different transactions. Voice recognition biometrics are most likely ...
(Date:2/7/2017)... Feb. 7, 2017   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... its innovative, highly flexible and award winning eClinical solution, ... iMedNet is a proven Software-as-a-Service (SaaS) clinical ... Capture (EDC), but also delivers an entire suite of ...
(Date:2/3/2017)... A new independent identity strategy consultancy firm ... . Designed to fill a critical niche in technical ... partners Mark Crego and Janice Kephart ... identity expertise that span federal governments, the 9/11 Commission, ... combined expertise has a common theme born from a ...
Breaking Biology News(10 mins):